{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:30:46Z","timestamp":1785335446716,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126527","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:45:01Z","timestamp":1731584701000},"page":"126527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Live-attenuated vaccine failure after liver transplantation: A 20-year cohort study"],"prefix":"10.1016","volume":"43","author":[{"given":"Munehiro","family":"Furuichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Yaginuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Shinjoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126527_bb0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126527_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13804","article-title":"A community divided: Post-transplant live vaccine practices among society of pediatric liver transplantation (SPLIT) centers","volume":"24","author":"Kemme","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.vaccine.2024.126527_bb0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.15585\/mmwr.mm6717a3","article-title":"Progress toward measles elimination - western Pacific region, 2013-2017","volume":"67","author":"Hagan","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.126527_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tmaid.2018.08.006","article-title":"Measles control in a measles-eliminated country, Japan","volume":"25","author":"Kinoshita","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126527_bb0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7883\/yoken.JJID.2018.083","article-title":"The largest measles outbreak, including 38 modified measles and 22 typical measles cases in its elimination era in yamagata, Japan, 2017","volume":"71","author":"Komabayashi","year":"2018","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126527_bb0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vaccine.2023.12.004","article-title":"Achieving measles elimination and emerging modified measles: longitudinal measles epidemiology from 1982 to 2021 in Osaka Prefecture, Japan","volume":"42","author":"Kurata","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7883\/yoken.JJID.2014.195","article-title":"Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012-2013 epidemics in Tokyo, Japan","volume":"68","author":"Sugishita","year":"2015","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126527_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231966","article-title":"Conjunctivitis, the key clinical characteristic\u00a0of adult rubella in Japan during two large outbreaks, 2012-2013 and 2018-2019","volume":"15","author":"Nomoto","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126527_bb0045","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.vaccine.2016.02.058","article-title":"Universal varicella vaccine immunization in Japan","volume":"34","author":"Yoshikawa","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0050","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1016\/j.vaccine.2023.06.054","article-title":"Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan","volume":"41","author":"Uda","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/21645515.2020.1765619","article-title":"Close the gap for routine mumps vaccination in Japan","volume":"17","author":"Kitano","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126527_bb0060","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1016\/j.vaccine.2014.06.022","article-title":"Recent progress and concerns regarding the Japanese immunization program: addressing the \u201cvaccine gap\u201d","volume":"32","author":"Saitoh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.728831","article-title":"Nationwide and long-term molecular epidemiologic studies of mumps viruses that circulated in Japan between 1986 and 2017","volume":"13","author":"Kidokoro","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.126527_bb0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2188\/jea.JE20200048","article-title":"Mumps-related disease burden in Japan: analysis of jmdc health insurance reimbursement data for 2005-2017","volume":"31","author":"Ohfuji","year":"2021","journal-title":"J Epidemiol"},{"key":"10.1016\/j.vaccine.2024.126527_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2188\/jea.JE20200233","article-title":"Incidence of mumps deafness in Japan, 2005-2017: analysis of Japanese insurance claims database","volume":"32","author":"Takagi","year":"2022","journal-title":"J Epidemiol"},{"key":"10.1016\/j.vaccine.2024.126527_bb0080","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1016\/j.vaccine.2008.09.076","article-title":"Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation","volume":"26","author":"Shinjoh","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0085","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.vaccine.2014.11.052","article-title":"Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation","volume":"33","author":"Shinjoh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2024.07.005","article-title":"Assessing clinical benefits of live-attenuated vaccination in post-liver transplant patients: analysis of breakthrough infections and natural boosters","author":"Shinjoh","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2024.126527_bb0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00007890-200208270-00020","article-title":"Efficacy and safety of immunization for pre- and post- liver transplant children","volume":"74","author":"Kano","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2024.126527_bb0100","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2015.01.075","article-title":"Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients","volume":"33","author":"Kawano","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0105","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/lt.24104","article-title":"Serostatus following live attenuated vaccination administered before pediatric liver transplantation","volume":"21","author":"Funaki","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.vaccine.2024.126527_bb0110","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.vaccine.2016.03.001","article-title":"Immunization practices in solid organ transplant recipients","volume":"34","author":"Miyairi","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0115","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1600-6143.2012.04273.x","article-title":"Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic","volume":"12","author":"Posfay-Barbe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2024.126527_bb0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ajt.15101","article-title":"Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation","volume":"19","author":"Pittet","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2024.126527_bb0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1399-3046.2005.00403.x","article-title":"Live virus immunization after orthotopic liver transplantation","volume":"10","author":"Khan","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.vaccine.2024.126527_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-3476(05)81545-8","article-title":"Measles vaccination after orthotopic liver transplantation","volume":"123","author":"Rand","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2024.126527_bb0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37602","article-title":"Safety and immunogenicity of live viral vaccines in a multicenter cohort of pediatric transplant recipients","volume":"6","author":"Feldman","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2024.126527_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transpl"},{"key":"10.1016\/j.vaccine.2024.126527_bb0145","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13571","article-title":"Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018","volume":"23","author":"Suresh","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2024.126527_bb0150","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1093\/infdis\/jir097","article-title":"Genetic characterization of measles vaccine strains","volume":"204","author":"Bankamp","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126527_bb0155","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/j.vaccine.2009.02.066","article-title":"Development of measles vaccines in Japan","volume":"27","author":"Ueda","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1099\/0022-1317-33-3-361","article-title":"Characterization of measles viruses in establishment of persistent infections in human lymphoid cell line","volume":"33","author":"Minagawa","year":"1976","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.126527_bb0165","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1099\/0022-1317-82-9-2143","article-title":"Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation","volume":"82","author":"Nakayama","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.126527_bb0170","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.vaccine.2005.06.036","article-title":"The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype","volume":"24","author":"Komase","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126527_bb0175","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/520449","article-title":"Measles inclusion-body encephalitis caused by the vaccine strain of measles virus","volume":"29","author":"Bitnun","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126527_bb0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrneph.2016.9","article-title":"Memory T cells in organ transplantation: progress and challenges","volume":"12","author":"Espinosa","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.vaccine.2024.126527_bb0185","first-page":"686","article-title":"B cell immunity in solid organ transplantation","volume":"7","author":"Karahan","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126527_bb0190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1086\/500144","article-title":"Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine","volume":"193","author":"Ovsyannikova","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126527_bb0195","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","article-title":"Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses","volume":"32","author":"Bonanni","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.126527_bb0200","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2401209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2401209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:43:33Z","timestamp":1734018213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2401209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S0264410X2401209X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126527","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live-attenuated vaccine failure after liver transplantation: A 20-year cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126527"}}